For curious women over 50
A clearer view of what comes next.
Semnal is an independent technology publication exploring the future of seeing, hearing and moving. We connect frontier research with everyday questions: what could change, what the evidence supports and how close a technology is to practical use.
You do not need a science background or a diagnosis to be curious about the future. Start with the question that interests you.
01 / READING PATH
Everyday possibilities
Start with familiar experiences: following a conversation, interpreting a scene or getting up and moving. These stories explore possibilities without assuming that every reader has the same needs.
- Sensory AI · 4 min read
Choosing one voice in a crowded room →
AI hearing assistance in noisy places starts with a deceptively hard task: choosing which voice to keep.
Research stage: Research prototype - Sensory AI · 2 min read
An image description is an interpretation, not eyesight →
AI image descriptions can help people with low vision read and explore. Seeing AI also shows why useful assistance needs clear limits.
Research stage: Software accessibility - Bionic Motion · 4 min read
A soft suit tackles the moment between sitting and walking →
A soft robotic suit helped older adults stand up in a small study. We examine the measured gains and the questions about everyday use.
Research stage: Human research
02 / READING PATH
Understand the evidence
Learn what was tested, whether women and older adults were represented, and which outcomes matter beyond a headline. Evidence from one group does not automatically apply to another.
- Beyond Lab · 4 min read
Were women included—and were their results examined? →
Health technology for women over 50 needs evidence that reflects its users. Start by asking who was included and how results were analysed.
Research stage: Evidence literacy - Beyond Lab · 4 min read
What counts as a meaningful improvement? →
For assistive technology, a meaningful outcome may be joining a conversation or finishing a familiar task. A technical score is only one part of that story.
Research stage: Outcome assessment - Beyond Lab · 4 min read
Approved, cleared, registered: three different claims →
FDA approved, cleared or authorised: what do these words actually tell you about a medical device, and what do they leave unanswered?
Research stage: Regulatory literacy
03 / READING PATH
Meet the makers
Follow companies working on sensing, neural interfaces and new materials. These are editorial profiles: research progress, practical questions and the work still ahead.
- Next Makers · 4 min read
Cionic puts sensing and stimulation into clothing →
Cionic's neural sleeve uses electrical stimulation to support movement. A company profile asks who it is intended for and what evidence to examine.
Research stage: Company-reported clinical evidence - Next Makers · 4 min read
Science Corporation and the work beyond a retinal chip →
Science announced PRIMA’s European launch in July 2026. The company now faces a different challenge: turning a retinal implant into a supported clinical service.
Research stage: European commercial launch announced; local access varies - Next Makers · 4 min read
Bioretec and the idea of a metal implant that does not stay →
Bioretec's absorbable metal fixation technology aims to support bone healing. A specific regulatory decision is not approval of every future application.
Research stage: Company-reported market development
Find your field of curiosity
Six desks, each with a different lens on the same question: what might technology make possible in everyday life?
Neural Edge →
Brain interfaces, hearing implants and neural signals.
Sensory AI →
AI for listening, seeing and navigating information.
Bionic Motion →
Wearable robotics and technology for movement.
Matter Lab →
Smart materials, textiles and soft sensors.
Beyond Lab →
Evidence, real-world access and what comes next.
Next Makers →
The companies developing tomorrow’s technology.
Read with the evidence in view
Our source-based articles distinguish studies, company claims and editorial interpretation. We explain limitations and identify what is still experimental. AI assistance is disclosed; a story is not a personal treatment recommendation or a claim of hands-on testing.